Prictor, M., Lewis, M.A., Newson, A.J., Haas, M., Baba, S., Kim, H., et al. (2019). Dynamic Consent: An Evaluation and Reporting Framework. J Empir Res Hum Res Ethics. [ePub ahead of print].
Haas, M.A., Boughtwood, T.F., & Quinn, M.C. (2019). The ethics approval process for multisite research studies in Australia: changes sought by the Australian Genomics initiative. Med J Aust, 211(10), 440-444.e441.
Nisselle, A., Martyn, M., Jordan, H., Kaunein, N., McEwen, A., Patel, C., et al. (2019). Ensuring Best Practice in Genomic Education and Evaluation: A Program Logic Approach. 10(1057).
Byrne AB, Arts P, Polyak SW, Feng J, Schreiber AW, Kassahn KS, et al. (2019). Identification and targeted management of a neurodegenerative disorder caused by biallelic mutations in SLC5A6. NPJ Genom Med.
Rius, R., Van Bergen, N.J., Compton, A.G., Riley, L.G., Kava, M.P., Balasubramaniam, S., et al. (2019). Clinical Spectrum and Functional Consequences Associated with Bi-Allelic Pathogenic PNPT1 Variants. J Clin Med, 8(11).
Crellin, E., McClaren, B., Nisselle, A., Best, S., Gaff, C., & Metcalfe, S. (2019). Preparing Medical Specialists to Practice Genomic Medicine: Education an Essential Part of a Broader Strategy. Frontiers in Genetics, 10(789).
Mallett, A.J., Quinlan, C., Patel, C., Fowles, L., Crawford, J., Gattas, M., et al. (2019). Precision Medicine Diagnostics for Rare Kidney Disease: Twitter as a Tool in Clinical Genomic Translation. Kidney Medicine.
Jayasinghe, K., White, S.M., Kerr, P.G., MacGregor, D., Stark, Z., Wilkins, E., et al. (2019). Isolated proteinuria due to CUBN homozygous mutation – challenging the investigative paradigm. BMC Nephrol, 20(1), 330.
Jayasinghe, K., Stark, Z., Patel, C., Mallawaarachchi, A., McCarthy, H., Faull, R., et al. (2019). Comprehensive evaluation of a prospective Australian patient cohort with suspected genetic kidney disease undergoing clinical genomic testing: a study protocol. 9(8), e029541.